NFKB1 and cancer: NF-κB signaling pathway indices (i.e., NF-κB, IκB, p-IκB, NF-κB mRNA, NF-κB activity, IKK, DNA-binding activity of NF-κB, and NF-κBp65) were examined either in normal cells or tissues (n = 9) or in inflammatory and cancer cells or tissue (n = 18).